Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Carrero, A; Berenguer, J; Hontanon, V; Guardiola, JM; Navarro, J; von Wichmann, MA; Tellez, MJ; Quereda, C; Santos, I; Sanz, J; Galindo, MJ; Hernandez-Quero, J; Jimenez-Sousa, MA; Perez-Latorre, L; Bellon, JM; Resino, S; Esteban, H; Martinez, E; Gonzalez-Garcia, J; Grp Estudio Sida GESIDA 36038 Stud.

Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients

CLINICAL INFECTIOUS DISEASES. 2021; 73(7): 2026-2033 Nº de citas: 9 [doi:10.1093/cid/ciaa1396]

Deutschmann, E; Bucher, HC; Jaeckel, S; Gibbons, S; McAllister, K; Scherrer, AU; Braun, DL; Cavassini, M; Hachfeld, A; Calmy, A; Battegay, M; Cipriani, M; Elzi, L; Young, J; Lopez-Centeno, B; Berenguer, J; Khoo, S; Moffa, G; Marzolini, C; Swiss HIV Cohort Study.

Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors

CLINICAL INFECTIOUS DISEASES. 2021; 73(7): 2145-2152 Nº de citas: 26 [doi:10.1093/cid/ciaa918]

Ryan, P; Valencia, J; Cuevas, G; Torres-Macho, J; Troya, J; Pueyo, A; Munoz-Gomez, MJ; Munoz-Rivas, N; Vazquez-Moron, S; Martinez, I; Lazarus, JV; Resino, S.

Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain

INTERNATIONAL JOURNAL OF DRUG POLICY. 2021; 96: 103424-103424 Nº de citas: 14 [doi:10.1016/j.drugpo.2021.103424]

Diez, C; Del Romero-Raposo, J; Mican, R; Lopez, JC; Blanco, JR; Calzado, S; Samperiz, G; Portilla, J; Garcia-Fraile, LJ; Gutierrez, F; Gomez-Sirvent, JL; Suarez-Garcia, I; Amador, C; Novella, M; Arribas, JR; Moreno, S; Gonzalez-Garcia, J; Jarrin, I; Berenguer, J; CoRIS.

COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

HIV MEDICINE. 2021; 22(9): 867-876 Nº de citas: 20 [doi:10.1111/hiv.13145]

De Gonzalo-Calvo, D; Benitez, ID; Pinilla, L; Carratala, A; Moncusi-Moix, A; Gort-Paniello, C; Molinero, M; Gonzalez, J; Torres, G; Bernal, M; Pico, S; Almansa, R; Jorge, N; Ortega, A; Bustamante-Munguira, E; Gomez, JM; Gonzalez-Rivera, M; Micheloud, D; Ryan, P; Martinez, A; Tamayo, L; Aldecoa, C; Ferrer, R; Ceccato, A; Fernandez-Barat, L; Motos, A; Riera, J; Menendez, R; Garcia-Gasulla, D; Penuelas, O; Torres, A; Bermejo-Martin, JF; Barbe, F; CIBERESUCICOVID PROJECT.

Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients

TRANSLATIONAL RESEARCH. 2021; 236: 147-159 Nº de citas: 117 [doi:10.1016/j.trsl.2021.05.004]

Perez-Garcia, F; Bailen, R; Torres-Macho, J; Fernandez-Rodriguez, A; Jimenez-Sousa, MA; Jimenez, E; Perez-Butragueno, M; Cuadros-Gonzalez, J; Cadinanos, J; Garcia-Garcia, I; Jimenez-Gonzalez, M; Ryan, P; Resino, S.

Age-Adjusted Endothelial Activation and Stress Index for Coronavirus Disease 2019 at Admission Is a Reliable Predictor for 28-Day Mortality in Hospitalized Patients With Coronavirus Disease 2019

Frontiers in Medicine. 2021; 8: 736028-736028 Nº de citas: 20 [doi:10.3389/fmed.2021.736028]

Teira, R; Diaz-Cuervo, H; Aragao, F; Munoz, J; Galindo, P; Merino, M; de la Fuente, B; Sepulveda, MA; Domingo, P; Garcia, J; Castano, M; Ribera, E; Geijo, P; Romero, A; Peraire, J; Deig, E; Roca, B; Martinez, E; Estrada, V; Montero, M; Berenguer, J; Espinosa, N.

eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort

HIV Research & Clinical Practice. 2021; 22(3): 78-85 Nº de citas: 3 [doi:10.1080/25787489.2021.1955197]

Berenguer, J; Borobia, AM; Ryan, P; Rodriguez-Bano, J; Bellon, JM; Jarrin, I; Carratala, J; Pachon, J; Carcas, AJ; Yllescas, M; Arribas, JR; COVID 19 Spain Grp.

Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score

THORAX. 2021; 76(9): 920-929 Nº de citas: 86 [doi:10.1136/thoraxjnl-2020-216001]

Pérez Lago L; Pérez Latorre L; Herranz M; Tejerina F; Sola-Campoy PJ; Sicilia J; Suárez-González J; Andrés-Zayas C; Chiner-Oms A; Jiménez-Serrano S; García-González N; Comas I; González-Candelas F; Martínez-Laperche C; Catalán P; Muñoz P; García de Viedma D.

Complete Analysis of the Epidemiological Scenario around a SARS-CoV-2 Reinfection: Previous Infection Events and Subsequent Transmission

mSphere. 2021; 6(5): Nº de citas: 2 [doi:10.1128/mSphere.00596-21]

Frontzek, F; Staiger, AM; Zapukhlyak, M; Xu, WD; Bonzheim, I; Borgmann, V; Sander, P; Baptista, MJ; Heming, JN; Berning, P; Wullenkord, R; Erdmann, T; Lutz, M; Veratti, P; Ehrenfeld, S; Wienand, K; Horn, H; Goodlad, JR; Wilson, MR; Anagnostopoulos, I; Lamping, M; Gonzalez-Barca, E; Climent, F; Salar, A; Castellvi, J; Abrisqueta, P; Menarguez, J; Aldamiz, T; Richter, J; Klapper, W; Tzankov, A; Dirnhofer, S; Rosenwald, A; Mate, JL; Tapia, G; Lenz, P; Miething, C; Hartmann, W; Chapuy, B; Fend, F; Ott, G; Navarro, JT; Grau, M; Lenz, G.

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma

Nature Communications. 2021; 12(1): 5183-5183 Nº de citas: 39 [doi:10.1038/s41467-021-25405-w]

Brochado-Kith, O; Martinez, I; Berenguer, J; Gonzalez-Garcia, J; Salguero, S; Sepulveda-Crespo, D; Diez, C; Hontanon, V; Ibanez-Samaniego, L; Perez-Latorre, L; Fernandez-Rodriguez, A; Jimenez-Sousa, MA; Resino, S.

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients

Frontiers in Immunology. 2021; 12: 723196-723196 Nº de citas: 23 [doi:10.3389/fimmu.2021.723196]

Ryan, P; Valencia, J; Cuevas, G; Troya, J; Torres-Macho, J; Munoz-Gomez, MJ; Munoz-Rivas, N; Canorea, I; Vazquez-Moron, S; Resino, S.

HIV screening and retention in care in people who use drugs in Madrid, Spain: a prospective study

Infectious Diseases of Poverty. 2021; 10(1): 111-111 Nº de citas: 3 [doi:10.1186/s40249-021-00894-5]

Perez-Lago, L; Aldamiz-Echevarria, T; Garcia-Martinez, R; Perez-Latorre, L; Herranz, M; Sola-Campoy, P; Suarez-Gonzalez, J; Martinez-Laperche, C; Comas, I; Gonzalez-Candelas, F; Catalan, P; Munoz, P; de Viedma, DG; Gregorio Maraiion Microbiology-ID.

Different Within-Host Viral Evolution Dynamics in Severely Immunosuppressed Cases with Persistent SARS-CoV-2

Biomedicines. 2021; 9(7): Nº de citas: 28 [doi:10.3390/biomedicines9070808]

Valencia, J; Troya, J; Lazarus, JV; Cuevas, G; Alvaro-Meca, A; Torres, J; Gardeta, C; Lozano, D; Moreno, S; Ryan, P.

Recurring Severe Injection-Related Infections in People Who Inject Drugs and the Need for Safe Injection Sites in Madrid, Spain

Open Forum Infectious Diseases. 2021; 8(7): [doi:10.1093/ofid/ofab251]

de Ory, SJ; Beltran-Pavez, C; Gutierrez-Lopez, M; Santos, MD; Prieto, L; Sainz, T; Guillen, S; Aguilera-Alonso, D; Diez, C; Bernardino, JI; Mellado, MJ; Ramos, JT; Holguin, A; Navarro, M.

Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(7): 1886-1892 Nº de citas: 1 [doi:10.1093/jac/dkab080]

Perez-Latorre, L; Berenguer, J; Mican, R; Montero, M; Cifuentes, C; Puig, T; Sanz, J; Ferrero, OL; de la Fuente, B; Rodriguez, C; Reus, S; Hernandez-Quero, J; Gaspar, G; Perez-Martinez, L; Garcia, C; Force, L; Veloso, S; De Miguel, M; Jarrin, I; Gonzalez-Garcia, J.

HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018

Eurosurveillance. 2021; 26(25): Nº de citas: 14 [doi:10.2807/1560-7917.ES.2021.26.25.2000236]

Tedim, AP; Almansa, R; Dominguez-Gil, M; Gonzalez-Rivera, M; Micheloud, D; Ryan, P; Mendez, R; Blanca-Lopez, N; Perez-Garcia, F; Bustamante, E; Gomez, JM; Doncel, C; Trapiello, W; Kelvin, AA; Booth, R; Ostadgavahi, AT; Oneizat, R; Puertas, C; Barbe, F; Ferrer, R; Menendez, R; Bermejo-Martin, JF; Eiros, JM; Kelvin, DJ; Torres, A.

Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2021; 51(6): Nº de citas: 28 [doi:10.1111/eci.13501]

Maggiolo, F; Rizzardini, G; Molina, JM; Pulido, F; De Wit, S; Vandekerckhove, L; Berenguer, J; D'Antoni, ML; Blair, C; Chuck, SK; Piontkowsky, D; Martin, H; Haubrich, R; McNicholl, IR; Gallant, J.

Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged >= 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial

Infectious Diseases and Therapy. 2021; 10(2): 775-788 Nº de citas: 46 [doi:10.1007/s40121-021-00419-5]